For Immediate Release:
March 28, 2025
Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in ad… [+4867 chars]
FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors - FDA.gov
Today, the FDA approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies).
By:Office of the Commissioner
Source:FDA.gov
Published:
Related News
Micron to invest $24 billion in Singapore plant as AI boom strains global memory supply - CNBC
Micron Technology has committed investments of $24 billion to expand its memory chip production within Singapore.
CNBC•Dylan Butts
General Motors is set to report earnings before the bell. Here's what Wall Street expects amid major electric vehicle write-downs - CNBC
GM plans to record $7.1 billion in special charges for the fourth quarter of 2025 related to its pullback in electric vehicles and restructuring in China.
CNBC•Michael Wayland
Fed expected to keep rates unchanged as Chair Powell pivots back to economics - AP News
After two weeks of intense political and legal scrutiny, the Federal Reserve will seek to make this week’s meeting about interest rates as straightforward and uneventful as possible, though President Donald Trump probably still won’t like the result. The cent…
Associated Press•Christopher Rugaber